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From January to September 2013, a marked increase 
in notifications of Salmonella Paratyphi A infections 
among travellers returning from Cambodia occurred in 
France. An investigation revealed 35 cases without a 
common source: 21 in France, five in Germany, three 
in the Netherlands, one in Norway, one in the United 
Kingdom, four in New-Zealand. Data suggest an ongo-
ing event that should trigger further investigation. 
Travellers to Cambodia should observe preventive 
measures including good personal hygiene and food 
handling practices.
In the first eight months of 2013, numbers of Salmonella 
Paratyphi A infections among travellers returning to 
France from Cambodia increased markedly while sev-
eral other countries also reported imported cases 
although to a lesser extent. Concurrently, an increase 
in S. Paratyphi A infections in Phnom Penh, Cambodia, 
starting in 2011 but with heightened numbers in 2013, 
was identified. Here we report mainly on the prelimi-
nary findings of the investigation of the French cases. 
Background 
Salmonella enterica serotype Paratyphi A only 
affects humans and is a cause of paratyphoid fever. 
Paratyphoid fever can also be caused by S. enterica 
serotypes Paratyphi B d-tartrate non-fermenting or 
Paratyphi C, and remains a major cause of morbidity 
in countries with poor sanitation, with an estimated 
5.5 million cases occurring annually [1]. In high-income 
countries, the majority of paratyphoid fever cases are 
imported from endemic regions. Transmission is fae-
cal-oral, through consumption of contaminated food 
or water, as well as person-to-person. The incubation 
period ranges from five to 21 days depending on the 
inoculum ingested. Acute illness is characterised 
by fever and malaise; other non-specific symptoms 
include headaches, abdominal pain, diarrhoea or con-
stipation, maculopapular rash and enlarged spleen. 
Chronic carriage can occur following acute infection. 
Reported case-fatality rate is approximately 1% and 
can be lowered by prompt use of adequate antibiotic 
therapy [2,3]. Resistance to various drugs including 
ampicillin, trimethoprim-sulfamethoxazole and qui-
nolones is increasing worldwide and effective treat-
ment requires adapted antibiotic therapy [4,5]. Good 
personal hygiene and food handling practices are the 
only preventive measures as there is no effective vac-
cine against paratyphoid infection [6]. 
Situation in France
In France, typhoid and paratyphoid fever have been 
notifiable diseases since 1903. In addition to manda-
tory reporting, clinical laboratories forward the iso-
lates to the National Reference Centre for Salmonella 
(NRC) at the Pasteur Institute in Paris on a voluntary 
basis. Between 2003 and 2012, 272 cases of paraty-
phoid A fever were reported (annual range: 18–36), 
including only seven cases among travellers returning 
from Cambodia. 
On 22 August 2013, the NRC notified the French 
National Institute for Public Health Surveillance (InVS) 
in Paris, about an unusual increase in the number of 
cases of paratyphoid A fever among travellers return-
ing from Cambodia: from 1 January to 22 August 2013, 
14 cases had been identified at the NRC. We initiated 
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an investigation to determine the magnitude of the 
event and to identify potential sources of infection.
Investigation of the event and results
We defined a case as culture-confirmed S. Paratyphi A 
infection diagnosed in 2013 in a person who reported a 
travel history to Cambodia in the month prior to symp-
tom onset. We merged data from both the NRC and 
the notifiable diseases surveillance system. Identified 
persons were contacted by phone, and demographics, 
clinical data, exposure history and details about their 
journey in Cambodia were collected using a specifically 
designed questionnaire.
As S. Paratyphi A is known to be a highly clonal organ-
ism that pulsed-field gel electrophoresis (PFGE) or mul-
tilocus sequence typing (MLST) techniques can hardly 
discriminate, the NRC focused microbiological charac-
terisation on antimicrobial susceptibility testing and 
attempted to discriminate isolates by using sequenc-
ing of the Clustered Regularly Interspaced Palindromic 
Repeats (CRISPR) contents, as previously described 
[7,8]. We carried out antimicrobial susceptibility test-
ing on all available S. Paratyphi A isolates by using the 
disk diffusion method, with a panel of 32 antimicro-
bial drugs (Bio-Rad, Marnes-La-Coquette, France). We 
determined the minimum inhibitory concentration (MIC) 
of ciprofloxacin, nalidixic acid and azithromycin using 
Etests (bioMérieux, Marcy l’Etoile, France), as previ-
ously described [9]. The results were then interpreted 
using the breakpoints of the Antibiogram Committee of 
the French Society for Microbiology (CA-SFM).
 On 28 August 2013, the InVS sent out an alert through 
the European Epidemic Intelligence Information System 
for Food- and Waterborne Diseases (EPIS-FWD) of the 
European Centre for Disease Prevention and Control 
(ECDC) to inform other European Union/European 
Economic Area (EU/EEA) Member States and associated 
national public health institutes about the event and to 
query about any recent increase in their reported cases 
of paratyphoid A fever with a travel history to Cambodia. 
Countries that responded and reported cases with a 
travel history to Cambodia in 2013 were contacted by 
ECDC to obtain additional information. Moreover, ECDC 
used the European Surveillance System (TESSy) to 
compare the number of cases with a travel history to 
Cambodia reported in the EU/EEA in 2013 with previ-
ous years. On 28 August, when available information 
suggested a multinational event, the French health 
authorities sent out an Early Warning Response System 
(EWRS) message, and on 4 September, ECDC posted a 
rapid risk assessment on its website to alert a wider 
audience about the event [10].
Cases notified in France 
In France, from 1 January to 20 September 2013, 21 
cases of paratyphoid A fever among persons with a 
travel history to Cambodia in the month prior to symp-
tom onset were reported. This represents a significant 
increase in the reported number of cases since only 
seven cases were reported between 2003 and 2012: 
two in 2003, three in 2004, one in 2005 and one in 
2012. Dates of symptom onset ranged from 30 January 
to 31 August 2013 (Figure) and dates for reported travel 
history to Cambodia ranged from 23 January to 27 
August.
  
Median age of infected persons was 40 years (range: 
4–65 years), 67% were female and 86% were hospi-
talised. Clinical data were available for 17/21 cases. 
Among patients for whom medical information was 
available, all presented with fever, 16/17 complained of 
asthenia, 13/17 had chills, 12/17 had diarrhoea, 11/17 
had headaches, 9/17 had abdominal pain and 4/17 had 
nausea or vomiting. Median length of hospitalisation 
was five days (range: 1–13). All patients fully recovered. 
Median length of stay in Cambodia was 19 days (range: 
4–81 days). Six persons experienced symptoms during 
their trip in Cambodia and 13 had symptom onset after 
their return home. For the six persons who had symp-
toms while in Cambodia, none sought medical atten-
tion during their trip, and median lag between arrival 
and symptom onset was 34 days (range: 11–61). For the 
13 persons who had symptoms after their departure 
from Cambodia, median lag between departure and 
symptom onset was 12 days (range: 2–26). 
One person continued to shed S. Paratyphi A in his 
urine four months after diagnosis, which caused sec-
ondary transmission to a household member who pre-
sented with bacteraemia. Illnesses occurred in tourists 
visiting Cambodia and travellers visiting relatives. 
Interviews did not identify any common exposure (such 
as hotel, restaurant, airline company or touristic site) 
that could explain all cases; 1/17 interviewee only vis-
ited the city of Phnom Penh, 2/17 interviewees visited 
Phnom Penh and Siem Reap areas only, and 14/17 vis-
ited at least three different cities. Overall, all 17 inter-
viewees visited Phnom Penh area, 12/17 visited Siem 
Figure
Cases of paratyphoid A fever among travellers returning 
from Cambodia by month of symptom onset, France, 2013 
(n=21)
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Reap area, 11/17 visited Sihanoukville area whereas 
other geographic areas were visited by less than 4/17 
interviewees. No common exposure or common activ-
ity was identified in Phnom Penh. Fourteen of the 21 
cases had solely travelled to Cambodia, whereas the 
remaining seven cases also reported brief travel to 
Thailand, Vietnam, Myanmar or China prior to symptom 
onset. The majority of interviewees reported consump-
tion of at-risk food items during their trip: 15/17 ate raw 
vegetables or drank raw fruit juices, 16/17 had drinks 
with ice, and 15/17 were not vaccinated against typhoid 
fever. 
S. Paratyphi A isolates were available at the NRC for 
18/21 cases with a travel history to Cambodia, which 
accounted for 45% of S. Paratyphi A isolates received at 
the NRC as of 20 September 2013. All isolates were fully 
susceptible to a panel of 32 antibiotics systematically 
tested at the NRC, including ampicillin, trimethoprim-
sulfamethoxazole, fluoroquinolones and azithromycin. 
A unique CRISPR profile was found in all 18 isolates 
and belonged to the dominant profile found in the NRC 
CRISPR database (36/48 S. Paratyphi A isolates).
Cases notified in other countries
Following the EPIS-FWD alert sent out by the InVS on 28 
August, Germany, the Netherlands, Norway, the United 
Kingdom (UK) and New Zealand reported cases of 
S. Paratyphi A infection identified in 2013 among trav-
ellers returning from Cambodia. Since 1 January 2013, 
35 cases of paratyphoid A fever have been reported 
among travellers returning from Cambodia including 
the 21 cases in France, five cases in Germany, three 
cases in the Netherlands, one case in Norway, one 
case in the UK, and four cases in New-Zealand. For the 
EU/EEA countries this represents a significant increase 
since only three imported cases from Cambodia were 
reported in the EU/EEA in 2012 (two by Germany, one 
by France). No reliable data were available for 2010 and 
2011. In addition to the 18 isolates tested in France, 
five additional isolates from other countries were avail-
able and were fully susceptible to all tested antibiotics. 
Austria, Czech Republic, Cyprus, Denmark, Estonia, 
Finland, Greece, Hungary, Ireland, Latvia, Lithuania, 
Malta, Portugal, Slovenia and Sweden reported having 
no cases in 2013 to date. 
The Table summarises the number of reported cases 
of paratyphoid A fever among travellers returning from 
Cambodia in 2013, in the EU/EEA and in New Zealand.
Discussion
A marked increase in imported cases of S. Paratyphi 
A infections from Cambodia to France occurred from 
January to September 2013. Other EU/EEA countries 
such as Germany, the Netherlands, Norway, the UK, 
as well as New Zealand also reported cases, although 
numbers might not differ from the expected baseline 
range. Occurrence of cases over several months among 
persons with travel history in different Cambodian 
geographic areas and without any common exposure 
identified despite in depth interviews suggests that 
sources of contamination are persistent and potentially 
multiple. All 17 French interviewees have visited Phnom 
Penh; however, Phnom Penh is the primary point of 
entry for travellers in Cambodia. Available informa-
tion from a referral hospital in Phnom Penh reported in 
this issue of Eurosurveillance by Vlieghe et al. shows a 
recent increase in S. Paratyphi A infections since March 
2013 in residents of Cambodia and particularly in the 
Phnom Penh area [11]. This study suggests that the 
rate of infection is higher in Phnom Penh compared to 
other regions of Cambodia. However, the study site is 
located in Phnom Penh and therefore, recruitment bias 
might have affected this finding. Further investigation 
should be conducted to determine affected areas and 
to identify sources of contamination of residents of 
Cambodia.
Table
Cases of paratyphoid A fever among travellers returning from Cambodia, reported in the EU/EEA and in New Zealand, 2013 
(n=35)
Country
Number of cases 
of paratyphoid A 
fever
Period of 
reporting (2013) Antibiotic resistance profile
France 21 Jan–Aug 18 isolates available, susceptible to all tested antibiotics
Germany 5 Jan–May 1 isolate available, susceptible to all tested antibiotics
The Netherlands 3 Mar–Apr All 3 isolates susceptible to all tested antibiotics
Norway 1 Apr Isolate susceptible to all tested antibiotics
United Kingdom 1 Apr No information available
New Zealand 4 May–Aug 1 isolate available, susceptible to all tested antibiotics except streptomycin
Total 35 Jan–Aug 23 isolates susceptible to all tested antibiotics
EU/EEA: European Union/European Economic Area.
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According to the Cambodian Ministry of Tourism data, 
121,175 French tourists travelled to Cambodia in 2012, 
versus 110,182 British, 72,537 Germans, 24,559 Dutch, 
8,251 Norwegians, and 19,044 New Zealanders [12]. 
Assuming that the number of travellers to Cambodia by 
country of residence in 2013 does not significantly dif-
fer from the 2012 data (available information suggests 
similar proportions up to May 2013), these statistics 
suggest that the large number of French tourists visit-
ing Cambodia could have contributed to the predomi-
nance of French nationals among the imported cases. 
Taking into account the number of travellers by coun-
try, the proportions of French, British, German, Dutch, 
Norwegians and New Zealanders among the cases 
are 1 per 5,770 French travellers, 1 per 110,182 British 
travellers, 1 per 14,507 German travellers, 1 per 8,186 
Dutch travellers, 1 per 8,251 Norwegian travellers, and 
1 per 4,761 New Zealander travellers. The observed dif-
ferences between countries might reflect differences 
in travel routes among international travellers, as well 
as in food habits during travel and in surveillance sys-
tems between European countries.
The strains’ full susceptibility profile to all antibiot-
ics tested appears common in southeast Asia whereas 
the spread of S. Paratyphi A strains resistant to qui-
nolones has been described in the Indian subconti-
nent [13]. CRIPSR typing results suggest that CRISPR 
typing was not sufficiently powerful in discriminating 
isolates. Further subtyping, i.e. PFGE analysis with two 
enzymes, of available isolates is ongoing.
Additional cases might occur if the source(s) of con-
tamination persists. However, spread within the EU/
EEA through secondary human-to-human transmission 
is expected to be limited: only one case of secondary 
transmission among household members has been 
documented in France so far. Clinicians in travel clinics 
and in infectious diseases hospitals should be alerted 
about the increase in the number of S. Paratyphi A 
infections among travellers returning from Cambodia. 
Advices about preventive measures, including personal 
hygiene and food handling practices, should be rein-
forced for travellers to Cambodia before their depar-
ture. As for other low and middle income countries, 
travellers to Cambodia should observe these measures 
and should seek medical attention as soon as pos-
sible should they present symptoms during their trip 
or after they returned in their country of residence. 
Although there is no efficient vaccine available against 
paratyphoid fever, travellers to Cambodia should con-
sider typhoid fever vaccine prior to their trip, unlike 
the majority of interviewed travellers described in this 
report, as data from Vlieghe et al. also strongly sug-
gest an ongoing increase in typhoid fever cases in 
Phnom Penh area [11] . 
Finally, whenever possible, travellers returning from 
Cambodia diagnosed with S. Paratyphi A infection 
should be interviewed by public health authorities; 
their travel route in Cambodia should be detailed and 
information should be shared with other countries and 
Cambodian health authorities to help shed light on any 
potential source of infection.
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